METTL5 and hepatocellular carcinoma: METTL5 is overexpressed in breast cancer,73 pancreatic cancer,74 uterine corpus endometrial carcinoma,75 and hepatocellular carcinoma (HCC),76 but significantly decreased in gastric cancer tissues compared to adjacent normal tissues and intestinal metaplasia tissues.77